Clinical Trials & Evidence Generation | Healthcare Brew

Adaptive Trial Design

Clinical Trial Transparency

Clinical Trials

Decentralized Trials

Patient Recruitment

Trial Diversity

Photo collage showing a close-up of a woman looking into a microscope next to falling pills, connected by neon yellow network nodes.

Experts are cautiously excited about ‘real-time’ FDA clinical trials

The FDA announced its idea for speedier drug approvals on April 28.

Caroline Catherman

A woman scanning a diabetes continuous glucose monitor on her arm with a phone

We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment

In the words of Leslie Knope: “Diabetes. Let’s dia-beat-this!”

Caroline Catherman

A portrait of Ben Zeskind, the CEO of oncology biotech company, Immunneering

Immuneering CEO shares his cancer drug development strategy

“Slow and steady” beats “flashy” when it comes to treating cancer, CEO Ben Zeskind says.

Caroline Catherman

illustration of pills with one shining under the spotlight of a microscope

Biotechs could save time, money from clinical trial rule change

Testing the safety and efficacy of medications will still depend on the company and the disease.

person with hands in their lap on left, brain and a hand holding mushrooms on right

Support for psychedelic treatments means full steam ahead at Compass, despite stock drop

Investors were seemingly not satisfied with psilocybin trial results, but the psychedelic health community disagrees.

Towana Looney, 53, who received a gene-edited pig kidney undergoes medical testing with Dr. Jeffrey Stern, MD at NYU Langone Health on December 11, 2024 in New York.

Pig kidney pioneers talk next steps, first-ever clinical trials at Orlando conference

Oink if you love science!

Caroline Catherman

Symmetrical illustration of replicated figure surrounding a large pill.

How digital twins could change clinical trials

Digital twins can cut time and costs associated with running drug studies.